There is no specific A1c number required to get a prescription for Ozempic. The FDA approves Ozempic for any adult with type 2 diabetes as an addition to diet and exercise, with no minimum or maximum A1c threshold written into the approval. However, your insurance company almost certainly has its own requirements, and that’s where a specific A1c level comes into play.
What the FDA Actually Requires
Ozempic (semaglutide) is approved for three uses in adults: improving blood sugar control in type 2 diabetes, reducing the risk of heart attacks and strokes in people with type 2 diabetes and existing heart disease, and protecting kidney function in people with type 2 diabetes and chronic kidney disease. All three indications require a diagnosis of type 2 diabetes. None specify an A1c cutoff.
This means a doctor can legally prescribe Ozempic whether your A1c is 6.5% or 12%, as long as you have type 2 diabetes. The 2025 American Diabetes Association guidelines reinforce this flexibility. They now recommend GLP-1 drugs like Ozempic based on a patient’s overall health picture, including heart disease risk, kidney health, and weight, rather than tying treatment decisions to a single A1c number.
What Insurance Companies Require
This is where the real gatekeeping happens. Most insurers require prior authorization before they’ll cover Ozempic, and their criteria are more specific than the FDA’s. A representative example from Johns Hopkins Health Plans shows the kind of checklist your insurer will likely use. They require documented evidence of type 2 diabetes, which typically means at least one of: an A1c of 6.5% or higher, a fasting blood sugar of 126 mg/dL or higher, or a random blood sugar of 200 mg/dL or higher with symptoms like excessive thirst or frequent urination.
So while there’s no universal A1c requirement for Ozempic, an A1c of 6.5% or above is effectively the floor for most insurance approvals because that’s the diagnostic threshold for type 2 diabetes itself. If your A1c doesn’t meet that mark, you likely don’t have a type 2 diabetes diagnosis, and insurers won’t cover Ozempic for weight loss alone.
The Metformin Step Requirement
Many insurance plans add another hurdle: you need to have tried metformin first. Specifically, plans often require documentation that you either took metformin at an optimal dose for at least three months without adequate blood sugar improvement or that you have a medical reason you can’t take it (such as kidney problems or severe gastrointestinal side effects). If your A1c remains above target after that metformin trial, insurers are far more likely to approve Ozempic. The specific A1c that counts as “inadequate response” varies by plan, but generally if you’re still above 7% after three months on metformin, you have a strong case.
How Much Ozempic Lowers A1c
For context on why doctors prescribe it, Ozempic is one of the most effective blood sugar medications available. In clinical trials, the standard 1 mg weekly dose lowered A1c by 1.5 to 1.8 percentage points over 30 to 56 weeks. The higher 2 mg dose, tested in the SUSTAIN FORTE trial with patients starting at an average A1c of 8.9%, brought levels down by 2.2 percentage points in 40 weeks. Real-world results tend to be slightly lower, with studies showing an average drop of about 1.2 percentage points, likely because people outside of clinical trials are less consistent with diet and dosing.
These reductions are significant. For someone starting at an A1c of 9%, getting down to around 7% can dramatically reduce the risk of diabetes complications affecting the eyes, kidneys, and nerves.
What If You Want It for Weight Loss
If you don’t have type 2 diabetes and want semaglutide for weight management, Ozempic isn’t the right prescription to pursue. Wegovy is the FDA-approved version of the same drug specifically indicated for weight loss. It requires a BMI of 30 or higher, or a BMI of 27 or higher with at least one weight-related condition like high blood pressure or high cholesterol. Wegovy does not require any particular A1c level.
Some doctors do prescribe Ozempic off-label for weight loss, but insurance plans rarely cover this use. Without coverage, the out-of-pocket cost runs over $900 per month. Your chances of getting insurance to pay for semaglutide are much better if you pursue Wegovy through its approved pathway, assuming you meet the BMI criteria, or Ozempic through its diabetes pathway with a documented A1c of 6.5% or higher and a trial of metformin.
How to Improve Your Chances of Approval
If you have type 2 diabetes and your doctor recommends Ozempic, a few practical steps can smooth the prior authorization process. Make sure your medical records include a recent A1c result (within the last few months), documentation of your metformin history (how long you took it, what dose, and why it wasn’t sufficient), and any relevant complications like heart disease or kidney problems. The additional FDA-approved indications for cardiovascular and kidney protection give your doctor more clinical justification to push back if your insurer initially denies the request.
If you’re denied, ask your doctor’s office to file an appeal. Many initial denials get overturned when the prescriber provides more detailed clinical notes. Some plans also have exceptions processes for patients who have tried and failed multiple other diabetes medications beyond metformin.